Stents Market by Stents Type (Coronary (Drug-Eluting, Bare-Metal Coronary, Bioabsorbable), Peripheral (Iliac, Femoral-Popliteal, Renal, Carotid), Stent-Related (Synthetic Grafts, Vena Cava Filters), Material (Metallic, Polymers, Natural)) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Get 20% Free Customization In This Report

Medical Devices & Supplies	LI_161603	Pages: 122	Aug 2016 \| 5302 Views
Author's : Deepa Tatkare	Tables: 42	Charts: 68	Formats*:

Stents Market Overview:

Stents Market is expected to garner $16,666 million by 2022. A stent is a tube like implant that is implanted into the lumen of any blood vessel or a duct in order to keep the passage open.

Varieties of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage of food and beverages in patients suffering from esophageal cancer. They are also inserted in the ureter to prevent obstruction of urine flow from kidney, in the gall bladder to allow passage of bile in patients suffering from gall bladder cancer, and in the abdomen & gastrointestinal tract. Stents are generally made of metals, polymers, and natural bioabsorbable materials.

The report covers the analysis of the stents market based on product type, biomaterial, and geography. The coronary stents segment is subsegmented into drug eluting stents, bare metal coronary stents, and bioabsorbable stents. Peripheral stents segment consists of iliac, femoral-popliteal, renal, and carotid stents. Furthermore, stents-related implants are further divided into synthetic grafts and vena cava filters. The report includes the revenue generated through sales of these aforementioned stents systems. The study excludes the revenue generated through post-sales services of stents.

World Stents Market Segmentation, By Product

Get more information on this report : Request Sample Pages

Segment Review:

According to the analysis done for each segment the coronary stents segment accounted for 48.5% of the overall stents market in 2015. It is also expected to grow at the highest CAGR of 9.5% in the forecast period. This market share and growth rate is attributed to the presence of significant players developing innovative technologies, increasing advances in the field of interventional cardiology coupled with the progress of minimally invasive techniques. This has greatly extended the potential of therapeutic applications of stents. Furthermore, coronary stents are sub segmented into, bare metal stents, drug-eluting stents, and bioabsorbable stents. The drug eluting stents has dominated the coronary stents market with its largest market share in 2015. However, the bioabsorbable stents are expected to be the highest growing market due to the unmet need for dissolvable stents.

LAMEA STENTS MARKET, BY REGION, 2015 (%)

Get more information on this report : Request Sample Pages

Brazil Stents Market Snapshot:

The Brazil stents market is growing rapidly due to improved healthcare system, growing economy and ageing population. In addition, presence of many interventional cardiologists has made Brazil a very strong market for the stents manufacturing industries. The Brazil stents market is expected to grow with a CAGR of 12.1% from 2015-2022.
Brazil Stents Market, 2014-2022 ($Million)

Brazil Stents Market, Forecast 2014-2022

Get more information on this report : Request Sample Pages

Top Impacting Factors

Growing elderly population and rise in prevalence of chronic diseases

Rising prevalence of chronic diseases coupled with the rapidly aging population worldwide is set to increase the demand for stent implants. According to WHO report, the population of people above 65 years was around 524 million in 2010, which is expected to grow to 1.5 billion by 2050; this would be 16% of the total world population. It is estimated that 27% of the Japanese, 16% of the U.S., 24% of the U.K., 17% of the Russian, and 14% of Chinese population will be above 65 years of age by 2020.

Technological advancements in the field of stents

Continuous technological innovations in the field of stent systems are set to drive the global stents market. Moreover, companies are spending a lot into R&D to create innovative products, for instance, Medtronic spend $1.640 billion for research and development in the year 2015, according to its annual report.

Global rise in acceptance of medical implants

The acceptance for medical implants has increased worldwide amongst patients and doctors. For instance, an increasing number of patients worldwide are opting for joint reconstruction surgeries to improve their quality of life. According to the U.S. National Center for Health Statistics, between 2001 and 2010, three has been an increase of 92% in the patients opting for total hip replacement for patients over 75 years of age while for patients in the age group 45-54 the rise has been a whopping 205%.

Improvement of healthcare infrastructure in developing countries

Over the past decade, the governments have increased their expenditure on the healthcare industry particularly in emerging nations. According to The World Bank data, China increased its healthcare expenditure from 5% in 2011 to 5.5 % of its GDP in 2015. Chile, Korea, and Turkey have increased their healthcare spending by 5% in 2013, according to OECD Health Statistics 2015.

High cost of treatment associated with stent implants

The cost of stents also increases with advancements in technology. For instance, drug eluting stents are costly as compared to bare metal stents. This high cost is a major restraint in the developing countries where most of the population does not have health insurance. The technologically advanced stents are too expensive for patients in developing countries.

Stringent approval process as these are highly specialized devices

The approval processes in most of the counties are very stringent for stents. As these are to be introduced in the body, they fall under Class II and III devices. It involves lots of time and investment for approval of stent systems. Recently, Boston Scientific SYNERGY Stent gained PMA approval after years of clinical trials. According to Advanced Medical Technology Association, it is estimated that about 77% and 80% of the total cost incurred in bringing a class II and class III medical device, respectively, to market is spend on FDA linked approval stages.

TOP IMPACTING FACTORS: STENTS MARKET

Stents Market Top Impacting Factors 2022

Get more information on this report : Request Sample Pages

KEY BENEFITS

This report offers the following benefits in particular:
An in-depth exposure to the world stents market is provided and light is shed on market dynamics that would prove crucial in understanding the market
Quantitative analysis of the current market and estimations through 2014-2022 would assist strategists to design business strategies to capitalize on the prevailing opportunities in the market
Porters Five Forces analysis examines the competitive structure of the world stents market and also provides a deeper understanding of the influence factors for market entry and market expansion
Pin-point analysis of geographic segments proffers identification of most profitable segments to capitalize on
Strategic analysis of the key leaders and their business strategies within the world stents market provided would assist stakeholders to make more informed business decisions

STENTS MARKET SEGMENTS

By Type

Coronary Stents
Drug-Eluting Stents (DES)
Bare-Metal Coronary Stents
Bioabsorbable Stents
Peripheral Stents
Iliac
Femoral-Popliteal
Renal
Carotid
Stent-Related Implants
Synthetic Grafts
Vena Cava Filters

By Material

Metallic Biomaterials
Polymers Biomaterials
Natural Biomaterials

By Region

North America
- U.S.
- Canada
- Mexic
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Malaysis
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Egypt
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes

3.4 Market share analysis, 2015
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Growing geriatric population and increasing prevalence of chronic diseases
3.5.1.2 Technological advancements in the field of stents
3.5.1.3 Improvement of healthcare infrastructure in developing countries
3.5.1.4 Improved insurance and reimbursement

3.5.2 Restraints

3.5.2.1 High cost of treatment associated with stent implants
3.5.2.2 Stringent approval process for stents

3.5.3 Opportunities

3.5.3.1 Huge market opportunities in the developing countries

Chapter: 4 WORLD STENTS MARKET, BY PRODUCT

4.1 Overview

4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast

4.2 Coronary stents

4.2.1 Market size and forecast
4.2.2 Drug-eluting stents (DES)

4.2.2.1 Market size and forecast

4.2.3 Bare-metal coronary stents

4.2.3.1 Market size and forecast

4.2.4 Bioabsorbable stents

4.2.4.1 Market size and forecast

4.3 Peripheral stents

4.3.1 Market size and forecast
4.3.2 Iliac stents

4.3.2.1 Market size and forecast

4.3.3 Femoral-popliteal stents

4.3.3.1 Market size and forecast

4.3.4 Renal & related stents

4.3.4.1 Market size and forecast

4.3.5 Carotid stents

4.3.5.1 Market size and forecast

4.4 Stent-related implants

4.4.1 Market size and forecast
4.4.2 Synthetic grafts

4.4.2.1 Market size and forecast

4.4.3 Vena cava filters

4.4.3.1 Market size and forecast

Chapter: 5 WORLD STENTS MARKET, BY BIOMATERIAL

5.1 Overview

5.1.1 Market size and forecast

5.2 Metallic biomaterials

5.2.1 Market size and forecast

5.3 Polymeric biomaterials

5.3.1 Market size and forecast

5.4 Natural biomaterials

5.4.1 Market size and forecast

Chapter: 6 WORLD STENTS MARKET, BY GEOGRAPHY, 20142022

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S. market size and forecast
6.2.5 Canada market size and forecast
6.2.6 Mexico market size and forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany market size and forecast
6.3.5 France market size and forecast
6.3.6 U.K. market size and forecast
6.3.7 Italy market size and forecast
6.3.8 Spain market size and forecast
6.3.9 Rest of Europe market size and forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 India market size and forecast
6.4.5 China market size and forecast
6.4.6 Japan market size and forecast
6.4.7 South Korea market size and forecast
6.4.8 Malaysia market size and forecast
6.4.9 Rest of Asia-Pacific market size and forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil market size and forecast
6.5.5 South Africa market size and forecast
6.5.6 Egypt market size and forecast
6.5.7 Rest of LAMEA market size and forecast

Chapter: 7 COMPANY PROFILES

7.1 Abbott Laboratories

7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategic moves & developments
7.1.5 SWOT analysis

7.2 B. Braun Melsungen AG

7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategic moves & developments
7.2.5 SWOT analysis

7.3 Biotronik SE & Co. KG

7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Key strategic moves & developments
7.3.4 SWOT analysis

7.4 Boston Scientific Corporation

7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & developments
7.4.5 SWOT analysis

7.5 C. R. Bard, Inc.

7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & developments
7.5.5 SWOT analysis

7.6 Elixir Medical Corporation

7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Key strategic moves & developments
7.6.4 SWOT analysis

7.7 Medtronic plc

7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & developments
7.7.5 SWOT analysis

7.8 Microport Scientific Corporation

7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & developments
7.8.5 SWOT analysis

7.9 Stentys S.A.

7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & developments
7.9.5 SWOT analysis

7.10 Terumo Corporation

7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategic moves & developments
7.10.5 SWOT analysis

List of Figures

FIG. 1 TOP INVESTMENT POCKETS IN WORLD STENTS MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (20142016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 4 PORTERS FIVE FORCES ANALYSIS
FIG. 5 MARKET SHARE ANALYSIS, 2015
FIG. 6 TOP IMPACTING FACTORS: STENTS MARKET
FIG. 7 DRUG-ELUTING STENTS MARKET, 20142022 ($MILLION)
FIG. 8 BARE-METAL CORONARY STENTS MARKET, 20142022 ($MILLION)
FIG. 9 BIOABSORBABLE STENTS MARKET, 20142022 ($MILLION)
FIG. 10 ILIAC STENTS MARKET, 20142022 ($MILLION)
FIG. 11 FEMORAL-POPLITEAL STENTS MARKET, 20142022 ($MILLION)
FIG. 12 RENAL & RELATED STENTS MARKET, 20142022 ($MILLION)
FIG. 13 CAROTID STENTS MARKET, 20142022 ($MILLION)
FIG. 14 SYNTHETIC GRAFTS MARKET, 20142022 ($MILLION)
FIG. 15 VENA CAVA FILTERS MARKET, 20142022 ($MILLION)
FIG. 16 U.S. STENTS MARKET, 20142022 ($MILLION)
FIG. 17 CANADA STENTS MARKET, 20142022 ($MILLION)
FIG. 18 MEXICO STENTS MARKET, 20142022 ($MILLION)
FIG. 19 GERMANY: STENTS MARKET, 20142022 ($MILLION)
FIG. 20 FRANCE: STENTS MARKET, 20142022 ($MILLION)
FIG. 21 U.K.: STENTS MARKET, 20142022 ($MILLION)
FIG. 22 ITALY: STENTS MARKET, 20142022 ($MILLION)
FIG. 23 SPAIN: STENTS MARKET, 20142022 ($MILLION)
FIG. 24 REST OF EUROPE: STENTS MARKET, 20142022 ($MILLION)
FIG. 25 INDIA: STENTS MARKET, 20142022 ($MILLION)
FIG. 26 CHINA: STENTS MARKET, 20142022 ($MILLION)
FIG. 27 JAPAN: STENTS MARKET, 20142022 ($MILLION)
FIG. 28 SOUTH KOREA: STENTS MARKET, 20142022 ($MILLION)
FIG. 29 MALAYSIA: STENTS MARKET, 20142022 ($MILLION)
FIG. 30 REST OF ASIA-PACIFIC STENTS MARKET, 20142022 ($MILLION)
FIG. 31 BRAZIL: STENTS MARKET, 20142022) ($MILLION)
FIG. 32 SOUTH AFRICA: STENTS MARKET, (20142022) ($MILLION)
FIG. 33 EGYPT: STENTS MARKET, 20142022 ($MILLION)
FIG. 34 REST OF LAMEA STENTS MARKET, 20142022 ($MILLION)
FIG. 35 ABBOTT - NET SALES, 20132015 ($MILLION)
FIG. 36 ABBOTT - REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 37 ABBOTT - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 38 ABBOTT - SWOT ANALYSIS
FIG. 39 B. BRAUN - NET SALES, 20132015 ($MILLION)
FIG. 40 B. BRAUN - REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 41 B. BRAUN - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 42 B. BRAUN - SWOT ANALYSIS
FIG. 43 BIOTRONIK - SWOT ANALYSIS
FIG. 44 BOSTON SCIENTIFIC - REVENUE, 20132015 ($MILLION)
FIG. 45 BOSTON SCIENTIFIC - REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 46 BOSTON SCIENTIFIC - CARDIOVASCULAR REVENUE, BY SUBSEGMENT, 2015 (%)
FIG. 47 BOSTON SCIENTIFIC - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 48 BOSTON SCIENTIFIC - SWOT ANALYSIS
FIG. 49 BARD: NET SALES, 20132015 ($MILLION)
FIG. 50 BARD: REVENUE, BY PRODUCT, 2015 (%)
FIG. 51 BARD: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 52 BARD - SWOT ANALYSIS
FIG. 53 ELIXIR MEDICAL - SWOT ANALYSIS
FIG. 54 MEDTRONIC: NET SALES, 20142016 ($MILLION)
FIG. 55 MEDTRONIC - REVENUE, BY SEGMENT, 2016 (%)
FIG. 56 MEDTRONIC - CARDIAC AND VASCULAR GROUP REVENUE, BY SUBSEGMENT, 2016 (%)
FIG. 57 MEDTRONIC - REVENUE, BY GEOGRAPHY, 2016 (%)
FIG. 58 MEDTRONIC - SWOT ANALYSIS
FIG. 59 MICROPORT - NET SALES, 20132015 ($MILLION)
FIG. 60 MICROPORT - REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 61 MICROPORT - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 62 MICROPORT - SWOT ANALYSIS
FIG. 63 STENTYS - NET SALES, 20132015 ($MILLION)
FIG. 64 STENTYS - SWOT ANALYSIS
FIG. 65 TERUMO - NET SALES, 20132015 ($MILLION)
FIG. 66 TERUMO - REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015(%)
FIG. 67 TERUMO - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 68 TERUMO - SWOT ANALYSIS

List of Tables

TABLE 1 WORLD STENTS MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 2 WORLD STENTS MARKET, BY PRODUCT, 20142022 (THOUSAND UNITS)
TABLE 3 CORONARY STENTS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 4 CORONARY STENTS MARKET, BY TYPE, 20142022 (THOUSAND UNITS)
TABLE 5 CORONARY STENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 6 PERIPHERAL STENTS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 7 PERIPHERAL STENTS MARKET, BY TYPE, 20142022 (THOUSAND UNITS)
TABLE 8 PERIPHERAL STENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 9 STENT-RELATED IMPLANTS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 10 STENT-RELATED IMPLANTS MARKET, BY TYPE, 20142022 (THOUSAND UNITS)
TABLE 11 STENT-RELATED IMPLANTS STENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 12 STENTS MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 13 STENTS MARKET FOR METALLIC BIOMATERIALS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 14 STENTS MARKET FOR POLYMERIC BIOMATERIALS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 15 STENTS MARKET FOR NATURAL BIOMATERIALS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 16 STENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 17 NORTH AMERICA: STENTS MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 18 NORTH AMERICA: STENTS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 19 EUROPE: STENTS MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 20 EUROPE: STENTS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 21 ASIA-PACIFIC: STENTS MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 22 ASIA-PACIFIC: STENTS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 23 LAMEA: STENTS MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 24 LAMEA: STENTS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 25 ABBOTT - COMPANY SNAPSHOT
TABLE 26 ABBOTT - OPERATING SEGMENTS
TABLE 27 B. BRAUN - COMPANY SNAPSHOT
TABLE 28 B. BRAUN - OPERATING SEGMENTS
TABLE 29 BIOTRONIK - COMPANY SNAPSHOT
TABLE 30 BIOTRONIK - OPERATING SEGMENTS
TABLE 31 BOSTON SCIENTIFIC - COMPANY SNAPSHOT
TABLE 32 BOSTON SCIENTIFIC - PRODUCT CATEGORIES
TABLE 33 BARD - COMPANY SNAPSHOT
TABLE 34 BARD - OPERATING SEGMENTS
TABLE 35 ELIXIR MEDICAL - COMPANY SNAPSHOT
TABLE 36 MEDTRONIC - COMPANY SNAPSHOT
TABLE 37 MEDTRONIC - OPERATING SEGMENTS
TABLE 38 MICROPORT - COMPANY SNAPSHOT
TABLE 39 MICROPORT - PRODUCT CATEGORIES
TABLE 40 STENTYS - COMPANY SNAPSHOT
TABLE 41 TERUMO - COMPANY SNAPSHOT
TABLE 42 TERUMO - PRODUCT CATEGORIES

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Stents Market Overview: